Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders
Open Access
- 29 September 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 13 (6), 559-562
- https://doi.org/10.1038/sj.gt.3302653
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1Gene Therapy, 2005
- Letter to the EditorRetina, 2004
- ErratumRetina, 2004
- MACULAR TRANSLOCATION SURGERY AND RETINAL CIRCULATION TIMESRetina, 2004
- VEGF‐TRAPR1R2 suppresses choroidal neovascularization and VEGF‐induced breakdown of the blood–retinal barrierJournal of Cellular Physiology, 2003
- Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti–Vascular Endothelial Growth Factor Antibody FragmentAmerican Journal of Ophthalmology, 2002
- Retinal and choroidal neovascularizationJournal of Cellular Physiology, 2000
- Targeted Disruption of the FGF2 Gene Does Not Prevent Choroidal Neovascularization in a Murine ModelThe American Journal of Pathology, 1998
- The Beaver Dam Eye Study: The Relation of Age-related Maculopathy to SmokingAmerican Journal of Epidemiology, 1993
- The Wisconsin Epidemiologic Study of Diabetic RetinopathyAmerican Journal of Ophthalmology, 1984